Literature DB >> 19836177

[Enteroviruses responsible for acute hemorrhagic conjunctivitis].

N Lévêque1, P Huguet, H Norder, J-J Chomel.   

Abstract

Acute hemorrhagic conjunctivitis (AHC) is an epidemic form of highly contagious conjunctivitis, characterized by conjunctival hemorrhages. The first AHC outbreak was described in 1969 in Ghana, West Africa, and was called Apollo disease, from the Apollo landing on the moon. This outbreak was caused by Enterovirus 70 (EV70) together with a Coxsackievirus A24 (CVA24v) variant, which are the major etiological agents involved in AHC outbreaks worldwide. AHC is known to be directly transmitted by close person-to-person contact or indirectly through soiled ophthalmological materials or unsafe recreational water. Recently, a possible airborne virus spread was suggested which could explain the high transmission rate of the disease. In the absence of a specific antiviral therapy, a rapid diagnosis of the causative agent is required to distinguish AHC due to enteroviruses from other ocular infectious diseases, for there are active drugs, or to quickly implement proper public health measures to limit the extension of the outbreak. However, virus identification remains difficult and time-consuming. Moreover, virological diagnosis is difficult to implement in developing countries where AHC has recently become a major problem for public health. Copyright 2009 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 19836177     DOI: 10.1016/j.medmal.2009.09.006

Source DB:  PubMed          Journal:  Med Mal Infect        ISSN: 0399-077X            Impact factor:   2.152


  7 in total

1.  Conjunctivitis: systematic approach to diagnosis and therapy.

Authors:  Onsiri Thanathanee; Terrence P O'Brien
Journal:  Curr Infect Dis Rep       Date:  2011-04       Impact factor: 3.725

2.  Role of enhanced receptor engagement in the evolution of a pandemic acute hemorrhagic conjunctivitis virus.

Authors:  Jim Baggen; Daniel L Hurdiss; Georg Zocher; Nitesh Mistry; Richard W Roberts; Jasper J Slager; Hongbo Guo; Arno L W van Vliet; Maryam Wahedi; Kimberley Benschop; Erwin Duizer; Cornelis A M de Haan; Erik de Vries; José M Casasnovas; Raoul J de Groot; Niklas Arnberg; Thilo Stehle; Neil A Ranson; Hendrik Jan Thibaut; Frank J M van Kuppeveld
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-28       Impact factor: 11.205

3.  A novel, broad-spectrum inhibitor of enterovirus replication that targets host cell factor phosphatidylinositol 4-kinase IIIβ.

Authors:  Hilde M van der Schaar; Pieter Leyssen; Hendrik J Thibaut; Armando de Palma; Lonneke van der Linden; Kjerstin H W Lanke; Céline Lacroix; Erik Verbeken; Katja Conrath; Angus M Macleod; Dale R Mitchell; Nicholas J Palmer; Hervé van de Poël; Martin Andrews; Johan Neyts; Frank J M van Kuppeveld
Journal:  Antimicrob Agents Chemother       Date:  2013-07-29       Impact factor: 5.191

4.  Acute hemorrhagic conjunctivitis: anti-coxsackievirus A24 variant secretory immunoglobulin A in acute and convalescent tear.

Authors:  Marlyn P Langford; Edwin A Anders; Maxwell A Burch
Journal:  Clin Ophthalmol       Date:  2015-09-10

5.  Environmental surveillance of poliovirus and non-polio enterovirus in urban sewage in Dakar, Senegal (2007-2013).

Authors:  Abdou Kader Ndiaye; Pape Amadou Mbathio Diop; Ousmane Madiagne Diop
Journal:  Pan Afr Med J       Date:  2014-11-04

6.  Frequency of adenovirus serotype 8 in patients with Keratoconjunctivitis, in Ahvaz, Iran.

Authors:  Kolsoom Shafiei; Manoochehr Makvandi; Ali Teimoori; Alireza Samarbafzadeh; Gholamreza Khataminia; Shahram Jalilian; Niloofar Neisi; Kimia Makvandi; Mehrdad Sadeghi Haj
Journal:  Iran J Microbiol       Date:  2019-04

7.  Genetic and phenotypic characterization of recently discovered enterovirus D type 111.

Authors:  Serge Alain Sadeuh-Mba; Marie-Line Joffret; Arthur Mazitchi; Marie-Claire Endegue-Zanga; Richard Njouom; Francis Delpeyroux; Ionela Gouandjika-Vasilache; Maël Bessaud
Journal:  PLoS Negl Trop Dis       Date:  2019-10-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.